• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cannabinoids, the Heart of the Matter.

作者信息

Alfulaij Naghum, Meiners Franziska, Michalek Justin, Small-Howard Andrea L, Turner Helen C, Stokes Alexander J

机构信息

Laboratory of Experimental Medicine, Department of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI.

Molecular Biosciences and Bioengineering, University of Hawaii, Honolulu, HI.

出版信息

J Am Heart Assoc. 2018 Jul 13;7(14):e009099. doi: 10.1161/JAHA.118.009099.

DOI:10.1161/JAHA.118.009099
PMID:30006489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6064852/
Abstract
摘要

相似文献

1
Cannabinoids, the Heart of the Matter.大麻素，问题的核心。
J Am Heart Assoc. 2018 Jul 13;7(14):e009099. doi: 10.1161/JAHA.118.009099.
2
The potential for clinical use of cannabinoids in treatment of cardiovascular diseases.大麻素在心血管疾病治疗中的临床应用潜力。
Cardiovasc Ther. 2011 Feb;29(1):17-22. doi: 10.1111/j.1755-5922.2010.00233.x. Epub 2010 Oct 14.
3
Cannabinoids and cardiovascular disease: the outlook for clinical treatments.大麻素与心血管疾病：临床治疗前景
Curr Vasc Pharmacol. 2007 Jul;5(3):175-85. doi: 10.2174/157016107781024109.
4
Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions.大麻素作为心血管疾病的治疗药物：一个充满激情与幻想的故事。
Br J Pharmacol. 2007 Jun;151(4):427-40. doi: 10.1038/sj.bjp.0707261. Epub 2007 Apr 23.
5
Naturally occurring and related synthetic cannabinoids and their potential therapeutic applications.天然存在的及相关合成大麻素及其潜在治疗应用。
Recent Pat CNS Drug Discov. 2009 Jun;4(2):112-36. doi: 10.2174/157488909788453031.
6
Cannabinoid system as a potential target for drug development in the treatment of cardiovascular disease.大麻素系统作为治疗心血管疾病药物研发的潜在靶点。
Curr Vasc Pharmacol. 2003 Oct;1(3):301-13. doi: 10.2174/1570161033476583.
7
[Function of cannabinoids in heart failure].[大麻素在心力衰竭中的作用]
Postepy Hig Med Dosw (Online). 2008 May 8;62:174-84.
8
Joints for joints: cannabinoids in the treatment of rheumatoid arthritis.关节对关节：大麻素治疗类风湿性关节炎。
Curr Opin Rheumatol. 2019 May;31(3):271-278. doi: 10.1097/BOR.0000000000000590.
9
Modulatory mechanisms of cannabinoids as a window of hope to patients with sleep-related cardiometabolic risk.大麻素的调节机制：为患有睡眠相关心脏代谢风险的患者带来希望的一扇窗。
Biomed Pharmacother. 2023 Dec;168:115721. doi: 10.1016/j.biopha.2023.115721. Epub 2023 Oct 16.
10
Cannabis and cannabinoids: pharmacology and rationale for clinical use.大麻与大麻素：药理学及临床应用原理
Forsch Komplementarmed. 1999 Oct;6 Suppl 3:12-5. doi: 10.1159/000057150.

引用本文的文献

1
Cannabidiol, Mitochondria, and PPAR-γ in Heart Failure: Walking on the Bright Side of the Moon?心力衰竭中的大麻二酚、线粒体与过氧化物酶体增殖物激活受体γ：漫步于月球的光明面？
JACC Basic Transl Sci. 2025 Jun;10(6):822-825. doi: 10.1016/j.jacbts.2025.02.007.
2
Epigenome-wide association study for dilated cardiomyopathy in left ventricular heart tissue identifies putative gene sets associated with cardiac pathology and early indicators of cardiac risk.对左心室心脏组织中扩张型心肌病进行的全表观基因组关联研究确定了与心脏病理学相关的假定基因集和心脏风险早期指标。
Clin Epigenetics. 2025 Mar 8;17(1):45. doi: 10.1186/s13148-025-01854-8.
3
The relationship between cannabis and cardiovascular disease: clearing the haze.大麻与心血管疾病之间的关系：拨开迷雾。
Nat Rev Cardiol. 2025 Jan 23. doi: 10.1038/s41569-025-01121-6.
4
Cardioprotective effect of CB1 receptor antagonist AM251 against β receptor-stimulated myocardial infarction via modulation of NF-kB signaling pathway in diabetic mice.CB1受体拮抗剂AM251通过调节糖尿病小鼠的NF-κB信号通路对β受体刺激引起的心肌梗死的心脏保护作用
Heliyon. 2024 Jul 24;10(15):e35138. doi: 10.1016/j.heliyon.2024.e35138. eCollection 2024 Aug 15.
5
Applications of Cannabinoids in Neuropathic Pain: An Updated Review.大麻素在神经病理性疼痛中的应用：最新综述。
Crit Rev Ther Drug Carrier Syst. 2024;41(1):1-33. doi: 10.1615/CritRevTherDrugCarrierSyst.2022038592.
6
Sigma-1 Receptor Signaling: In Search of New Therapeutic Alternatives for Cardiovascular and Renal Diseases.Sigma-1 受体信号转导：寻找心血管和肾脏疾病的新治疗选择。
Int J Mol Sci. 2023 Jan 19;24(3):1997. doi: 10.3390/ijms24031997.
7
How do phytocannabinoids affect cardiovascular health? An update on the most common cardiovascular diseases.植物大麻素如何影响心血管健康？关于最常见心血管疾病的最新情况。
Ther Adv Chronic Dis. 2023 Jan 6;14:20406223221143239. doi: 10.1177/20406223221143239. eCollection 2023.
8
Pharmacognosy and Effects of Cannabinoids in the Vascular System.大麻素在血管系统中的生药学及作用
ACS Pharmacol Transl Sci. 2022 Oct 28;5(11):1034-1049. doi: 10.1021/acsptsci.2c00141. eCollection 2022 Nov 11.
9
Nabiximols effect on blood pressure and heart rate in post-stroke patients of a randomized controlled study.纳布西莫尔对卒中后患者血压和心率影响的一项随机对照研究
Front Cardiovasc Med. 2022 Oct 28;9:990188. doi: 10.3389/fcvm.2022.990188. eCollection 2022.
10
The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases.内源性大麻素系统在年龄相关性疾病中的治疗潜力
Biomedicines. 2022 Oct 6;10(10):2492. doi: 10.3390/biomedicines10102492.

本文引用的文献

1
Lifetime marijuana use and subclinical atherosclerosis: the Coronary Artery Risk Development in Young Adults (CARDIA) study.终生吸食大麻与亚临床动脉粥样硬化：年轻人冠状动脉风险发展（CARDIA）研究。
Addiction. 2018 May;113(5):845-856. doi: 10.1111/add.14110. Epub 2018 Jan 21.
2
Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution: Part 3 of a 3-Part Series.氧化应激与心血管风险：肥胖、糖尿病、吸烟及污染：系列文章之三（共三篇）
J Am Coll Cardiol. 2017 Jul 11;70(2):230-251. doi: 10.1016/j.jacc.2017.05.043.
3
Impact of Oxidative Stress on the Heart and Vasculature: Part 2 of a 3-Part Series.氧化应激对心脏和血管系统的影响：三部曲系列的第2部分。
J Am Coll Cardiol. 2017 Jul 11;70(2):212-229. doi: 10.1016/j.jacc.2017.05.035.
4
Cumulative Lifetime Marijuana Use and Incident Cardiovascular Disease in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.中年时期大麻使用累积量与心血管疾病发病情况：青年成人冠状动脉风险发展研究（CARDIA研究）
Am J Public Health. 2017 Apr;107(4):601-606. doi: 10.2105/AJPH.2017.303654. Epub 2017 Feb 16.
5
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.《2017年心脏病和中风统计数据更新：美国心脏协会报告》
Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25.
6
Effects of Neuroendocrine CB1 Activity on Adult Leydig Cells.神经内分泌CB1活性对成年睾丸间质细胞的影响。
Front Endocrinol (Lausanne). 2016 Jun 3;7:47. doi: 10.3389/fendo.2016.00047. eCollection 2016.
7
The role of autophagy in cardiac hypertrophy.自噬在心肌肥大中的作用。
Acta Biochim Biophys Sin (Shanghai). 2016 Jun;48(6):491-500. doi: 10.1093/abbs/gmw025. Epub 2016 Apr 15.
8
Pharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscle.饮食诱导肥胖中大麻素CB1受体的药理学阻断调节肌肉中的线粒体二氢硫辛酰胺脱氢酶。
PLoS One. 2015 Dec 15;10(12):e0145244. doi: 10.1371/journal.pone.0145244. eCollection 2015.
9
Role of principal ionotropic and metabotropic receptors in visceral pain.主要离子型和代谢型受体在内脏痛中的作用。
J Neurogastroenterol Motil. 2015 Mar 30;21(2):147-58. doi: 10.5056/jnm15026.
10
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.阿利西尤单抗降低血脂和心血管事件的疗效和安全性。
N Engl J Med. 2015 Apr 16;372(16):1489-99. doi: 10.1056/NEJMoa1501031. Epub 2015 Mar 15.